Corvus Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €91.97M +86.4% €36.49M -281.2% 39.7% +0.81 pp N/A N/A
    (estimated) €49.33M +273.6% -€20.14M -58.2% -40.8% +3.2 pp N/A N/A
    (estimated) €13.20M +∞% -€48.15M +6.0% -364.7% -3.6 pp N/A N/A
    (estimated) N/A -€45.43M +304.1% N/A N/A N/A
    (estimated) N/A -€11.24M -78.8% N/A N/A N/A
    €0.00 +NaN% -€53.13M +130.5% N/A -€21.69M +6.4% N/A
    €0.00 +NaN% -€23.05M -34.6% N/A -€20.39M -10.7% N/A
    €0.00 +NaN% -€35.23M -4.5% N/A -€22.82M -27.1% N/A
    €0.00 +NaN% -€36.88M +621.3% N/A -€31.31M +5.8% N/A
    €0.00 +NaN% -€5.11M -87.2% N/A -€29.60M -7.0% N/A
    €0.00 +NaN% -€39.81M -0.6% N/A -€31.81M -8.2% N/A
    €0.00 +NaN% -€40.04M -15.7% N/A -€34.66M -11.6% N/A
    €0.00 +NaN% -€47.48M +53.0% N/A -€39.19M +79.1% N/A
    €0.00 +NaN% -€31.03M +16.1% N/A -€21.89M +167.8% N/A
    €0.00 +NaN% -€26.73M +17,704.0% N/A -€8.17M +9,048.5% N/A
    €0.00 -€150.12K N/A -€89.33K N/A

    Notifications